CVS Health Corporation (CVS)
CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript
CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript
CVS Health: Stop Catastrophizing, Start Believing - Here's Why
CVS Health Corporation is rated a Buy, with a bullish outlook for 2026–2027 driven by margin recovery and undervalued valuation metrics. CVS trades at attractive forward P/S (~0.25x) and P/E (~13x), with potential for >50% share price upside if Medicare Advantage margins recover. 2026 guidance projects improved Medical Benefit Ratio, rising GAAP EPS ($6.04), and margin expansion across all divisions despite flat revenues.
CVS Health And Google Launch AI Business To ‘Personalize Healthcare'
CVS Health and Google have partnered to use artificial intelligence and related cloud-based technology to increase consumer and patient engagement, and "ultimately support better health outcomes,” the companies said Thursday.
CVS taps Google Cloud to roll out AI-powered health platform
CVS Health will launch an AI-enabled platform in partnership with Alphabet's Google Cloud unit that will bring together data from diverse sources to help customers manage their health in real time, they said on Thursday.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Here's Why CVS Health (CVS) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why CVS Health (CVS) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market
CVS beats Q4 earnings and revenue estimates, but higher costs squeeze margins. Shares slip pre-market despite upbeat 2026 EPS guidance.
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
CVS Health (CVS) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CVS Health posts strong Q4 revenue, raises full-year guidance
CVS Health Corp (NYSE:CVS) on Tuesday reported stronger-than-expected fourth-quarter revenue and adjusted earnings, driven by growth across its pharmacy, health services, and insurance businesses. The US pharmacy chain and health insurer said fourth-quarter revenue rose 8.2% to $105.7 billion, topping analysts' expectations of $103.6 billion.
